Protect Pharmaceutical Profit Margin

The latest profit margin for PRTT is 25.33% as of June 2026. That compares with 42.59% in the prior-year period — down 40.5% year over year. That is above the sector sector average of 13.23%. Investors often review this figure alongside Protect Pharmaceutical's historical trend and sector peers before judging valuation or financial health.

Over the past year, PRTT's profit margin moved from 42.59% to 25.33% — a 40.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Protect Pharmaceutical's valuation or profitability profile.

Against its sector companies, PRTT currently prints 25.33% for profit margin, while the sector average sits near 13.23%. That is roughly 91.5% above the sector mean. Large gaps often invite a closer look at Protect Pharmaceutical's growth, margins, and balance sheet.

Profit Margin shows how effectively Protect Pharmaceutical converts resources into returns. At 25.33%, PRTT may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 42.59% in the prior-year period — down 40.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting PRTT's profit margin (25.33%), review year-over-year change from 42.59%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.